Statin and metformin therapy in prostate cancer patients with hyperlipidemia who underwent radiotherapy: a population-based cohort study

References

• ChiangCJLoWCYangYWYouSLChenCJLaiMSIncidence and survival of adult cancer patients in Taiwan, 2002-2012J Formos Med Assoc2016115121076108826786251
   PubMed Web of Science ®Google Scholar
• HungCFYangCKOuYCUrologic cancer in TaiwanJpn J Clin Oncol201646760560927052114
   PubMed Web of Science ®Google Scholar
• PuYSProstate cancer in Taiwan: epidemiology and risk factorsInt J Androl200023Suppl 2343610849490
   PubMedGoogle Scholar
• HamiltonRJGoldbergKCPlatzEAFreedlandSJThe influence of statin medications on prostate-specific antigen levelsJ Natl Cancer Inst2008100211511151818957682
   PubMedGoogle Scholar
• ChangSLHarshmanLCPrestiJCImpact of common medications on serum total prostate-specific antigen levels: analysis of the national health and nutrition examination surveyJ Clin Oncol201028253951395720679596
   PubMed Web of Science ®Google Scholar
• Cyrus-DavidMSWeinbergAThompsonTKadmonDThe effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary reportJ Urol200517361923192515879782
   PubMed Web of Science ®Google Scholar
• MondulAMSelvinEDe MarzoAMFreedlandSJPlatzEAStatin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004Cancer Causes Control201021567167820072809
   PubMed Web of Science ®Google Scholar
• NordströmTClementsMKarlssonRAdolfssonJGrönbergHThe risk of prostate cancer for men on aspirin, statin or antidiabetic medicationsEur J Cancer201551672573325727881
   PubMed Web of Science ®Google Scholar
• AllottEHFarnanLSteckSEStatin use, high cholesterol and prostate cancer progression; results from HCaP-NCProstate2018781185786429717502
   PubMed Web of Science ®Google Scholar
• ChenYALinYJLinCLSimvastatin therapy for drug repositioning to reduce the risk of prostate cancer mortality in patients with hyperlipidemiaFront Pharmacol2018922529623039
   PubMed Web of Science ®Google Scholar
• NielsenSFNordestgaardBGBojesenSEStatin use and reduced cancer-related mortalityN Engl J Med20133686576577
   PubMedGoogle Scholar
• TanPWeiSYangLThe effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysisSci Rep201662910627384548
   PubMed Web of Science ®Google Scholar
• ParkHSSchoenfeldJDMailhotRBStatins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysisAnn Oncol20132461427143423508824
   PubMed Web of Science ®Google Scholar
• GuttRTonlaarNKunnavakkamRKarrisonTWeichselbaumRRLiauwSLStatin use and risk of prostate cancer recurrence in men treated with radiation therapyJ Clin Oncol201028162653265920421534
   PubMed Web of Science ®Google Scholar
• CaonJPaquetteMHammJPicklesTDoes statin or ASA affect survival when prostate cancer is treated with external beam radiation therapy?Prostate Cancer20142014416
   Google Scholar
• PlatzEATangenCMGoodmanPJStatin drug use is not associated with prostate cancer risk in men who are regularly screenedJ Urol2014192237938424518774
   PubMed Web of Science ®Google Scholar
• FreedlandSJHamiltonRJGerberLStatin use and risk of prostate cancer and high-grade prostate cancer: results from the reduce studyProstate Cancer Prostatic Dis201316325425923567655
   PubMed Web of Science ®Google Scholar
• AkinyekeTMatsumuraSWangXMetformin targets c-myc oncogene to prevent prostate cancerCarcinogenesis201334122823283224130167
   PubMed Web of Science ®Google Scholar
• Ben SahraILaurentKLoubatAThe antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 levelOncogene200827253576358618212742
   PubMed Web of Science ®Google Scholar
• LeeSYSongCHXieYBJungCChoiHSLeeKSMILE upregulated by metformin inhibits the function of androgen receptor in prostate cancer cellsCancer Lett2014354239039725199764
   PubMed Web of Science ®Google Scholar
• NguyenHGYangJCKungHJTargeting autophagy overcomes enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft modelOncogene201433364521453024662833
   PubMed Web of Science ®Google Scholar
• ZingalesVDistefanoARaffaeleMZanghiABarbagalloIVanellaLMetformin: a bridge between diabetes and prostate cancerFront Oncol2017724329075616
   PubMed Web of Science ®Google Scholar
• WhitburnJEdwardsCMSooriakumaranPMetformin and prostate cancer: a new role for an old drugCurr Urol Rep20171864628444639
   PubMed Web of Science ®Google Scholar
• MayerMJKlotzLHVenkateswaranVThe effect of metformin use during docetaxel chemotherapy on prostate cancer specific and overall survival of diabetic patients with castration resistant prostate cancerJ Urol201719741068107527984108
   PubMed Web of Science ®Google Scholar
• TairaAVMerrickGSGalbreathRWMorrisMButlerWMAdamovichEMetformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapyJ Contemp Brachytherapy20146325426125337126
   PubMed Web of Science ®Google Scholar
• CoyleCCaffertyFHValeCLangleyREMetformin as an adjuvant treatment for cancer: a systematic review and meta-analysisAnn Oncol201627122184219527681864
   PubMed Web of Science ®Google Scholar
• DengDYangYTangXAssociation between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysisDiabetes Metab Res Rev201531659560225708557
   PubMed Web of Science ®Google Scholar
• LiuYHuangCCengCZhanHZhengDHanWMetformin enhances nitric oxide production and diminishes Rho kinase activity in rats with hyperlipidemiaLipids Health Dis20141311525028180
   PubMed Web of Science ®Google Scholar
• ChengSHChiangTLThe effect of universal health insurance on health care utilization in Taiwan. Results from a natural experimentJAMA1997278289939214512
   PubMed Web of Science ®Google Scholar
• ChiangCLChenPCHuangLYImpact of universal health coverage on urban-rural inequity in psychiatric service utilisation for patients with first admission for psychosis: a 10-year nationwide population-based study in TaiwanBMJ Open201663e010802
   PubMed Web of Science ®Google Scholar
• ShenCCHuLYHuYHComorbidity study of borderline personality disorder: applying association rule mining to the Taiwan National health insurance Research DatabaseBMC Med Inform Decis Mak2017171828077135
   PubMedGoogle Scholar
• HutchinsonJMarignolLClinical potential of statins in prostate cancer radiation therapyAnticancer Res201737105363537228982844
   PubMed Web of Science ®Google Scholar
• RavalADThakkerDNegiHVyasAKaurHSalkiniMWAssociation between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysisProstate Cancer Prostatic Dis201619215116226782711
   PubMed Web of Science ®Google Scholar
• YuOEbergMBenayounSUse of statins and the risk of death in patients with prostate cancerJ Clin Oncol201432151124190110
   PubMed Web of Science ®Google Scholar
• MucciLAKantoffPWIs the evidence sufficient to recommend statins for all men with prostate cancer?J Clin Oncol201735293272327428817369
   PubMed Web of Science ®Google Scholar
• LarsenSBDehlendorffCSkriverCPostdiagnosis statin use and mortality in Danish patients with prostate cancerJ Clin Oncol201735293290329728806117
   PubMed Web of Science ®Google Scholar
• HarshmanLCWangXNakabayashiMStatin use at the time of initiation of androgen deprivation therapy and time to progression in patients with hormone-sensitive prostate cancerJAMA Oncol20151449550426181260
   PubMed Web of Science ®Google Scholar
• Cholesterol Treatment Trialists’ (CTT) CollaborationEmbersonJRKearneyPMLack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapyPLoS One201271e2984922276132
   PubMed Web of Science ®Google Scholar
• LiuXLiJSchildSEStatins and metformin use is associated with lower PSA levels in prostate cancer patients presenting for radiation therapyJ Cancer Ther201782738528239505
   PubMedGoogle Scholar
• MargelDUrbachDRLipscombeLLMetformin use and all-cause and prostate cancer-specific mortality among men with diabetesJ Clin Oncol201331253069307523918942
   PubMed Web of Science ®Google Scholar
• XiaoYZhengLMeiZThe impact of metformin use on survival in prostate cancer: a systematic review and meta-analysisOncotarget201785910044910045829245991
   PubMedGoogle Scholar
• BensimonLYinHSuissaSPollakMNAzoulayLThe use of metformin in patients with prostate cancer and the risk of deathCancer Epidemiol Biomarkers Prev201423102111211825017246
   PubMed Web of Science ®Google Scholar
• StopsackKHZiehrDRRiderJRGiovannucciELMetformin and prostate cancer mortality: a meta-analysisCancer Causes Control201627110511326537119
   PubMed Web of Science ®Google Scholar
• FerroAGoyalSKimSEvaluation of diabetic patients with breast cancer treated with metformin during adjuvant radiotherapyInt J Breast Cancer20132013Article ID 659723
   PubMedGoogle Scholar